4Chapman M D, Hanrahan B, McEwen J, et al. Hyponatraemia and hypokalaemia due to indapamide[J]. The Medical Journal of Australia, 2002,176(5) :219- 221. 被引量：1
3[1]Josse R, Thomas. A review of 10 years of experience with indapamide as an antihypertensive agent[J].Hypertension, 1985,7:SupplⅡ152-1155. 被引量：1
4[2]Morledge JH. Clinical efficacy and safety of indapamide in essentialhypertension[J].Am Heart J,1983,106:229-232. 被引量：1
5[3]Wheeley MSTG, Bolton JC, Campbekk DB. Indapamide in hypertension: a study in general practice of new or previously poorly controlled patients[J].Pharmocotherap-eutica,1982,3:143-152. 被引量：1
6[4]Andries EW, Brems HM, Clement DL. Long-term effects of indapamide in patients with essential hypertension[J].Excerpta Medica, 1980:182-190. 被引量：1
7[5]Belings, Vukovich RA, Neiss ES, Zisblatt M. Long-term experience with indapamide[J].Am Heart J,1983,106:258-262. 被引量：1
8[6]Anavekar SN, Ludbrook A, louis WJ. Evalution of indapamide in the treatment of hypertension[J].J Cardiovasc Pharmocol,1979,1:389-394. 被引量：1
9[7]Rowlands DB, Glover DR, Young MA. Once-daily indapamide in the treatment of the elderly and young hypertensive[J].Eur J Clin Pharmocal,1984,27:397-405. 被引量：1
10[8]Donald Weidler MD, Nadeer S, Jallad phD, et al. Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension[J].J Clin pharmacol,1995,35:45-51. 被引量：1
2Aaseth JO,Tangen MK,Beitnes JO.Hypotuttremic crisis:a serious side effect of diuretics in the elderly[J].Tidsskr Nor Laegeforen,2001,121:921-923. 被引量：1
